Rates of protein synthesis in vivo in normal and pathological tissues of the gastrointestinal tract, were measured using the 'flooding dose' technique with the stable isotope L-[1-'C] leucine. The rate of protein synthesis in normal colonic mucosa was 9.4 (1.2)% (mean (SEM)) per day but was significantly raised in benign and malignant colorectal tumour tissue, and in colonic mucosa from patients with inflammatory bowel disease (p<0.001). Furthermore, the rate of protein synthesis was significantly greater in benign colorectal tumour tissue, 36.7 (2 5)% per day, than that in either malignant tumour tissue, 21.7 (1.9)% per day, or in inflammatory bowel disease mucosa, 24.7 (2.5)% per day (means (SEM) p<0001). Liver protein synthesis rates were also measured in separate groups of patients with benign disease of the gastrointestinal tract, in patients with colorectal carcinoma, and in patients with inflammatory bowel disease. The fractional rate of liver protein synthesis was 20O7 (1.9)% per day in patients with benign disease and 23.1 (1.6)% per day in patients with colorectal cancer. In patients with inflammatory bowel disease, however, liver protein synthesis was significantly increased to 35 4 (2.3)% per day (means (SEM) p<0.01).
The development of weight loss and malnutrition, with a concomitant loss of body nitrogen, reduced nitrogen intake and reduction in lean body mass, are well recognised findings in patients with benign or malignant disease of the colon.'2 With inflammatory bowel disease, the loss of protein through the gastrointestinal tract is also a contributory factor.23 Previous investigations of protein metabolism in these clinical disorders have centred on measurements of whole body protein turnover. In the presence of a malignant tumour -for example, lung or colon, increases in whole body protein synthesis and breakdown have been reported,45 although other studies have detected no change.67 Rises in whole body turnover rates have also been seen in patients with inflammatory bowel disease. Moreover, the increased rate of protein synthesis and breakdown correlated with the severity of the disease activity, as assessed from the patients erythrocyte sedimentation rates. 8 These studies of whole body protein metabolism, however, simply reflect an average of events occurring in all individual tissues. In the presence of malignancy it is known that different tissues can respond in different ways. For example, Pain et al9 have shown that in experimental tumour-bearing animals, protein synthesis was decreased in skeletal muscle but increased in liver when compared with nontumour bearing controls. Similarly in man, in patients with bronchial carcinoma there was a decrease in skeletal muscle protein synthesis but no change in whole body protein synthesis, when compared with control patients without malignant disease.'0 Measurement of protein synthesis in individual tissues is therefore advantageous when further investigating these abnormalities in protein metabolism, but in the past this has usually required animal studies.
Tumour protein synthesis has been previously measured in man by constant A standard anaesthetic regimen was used in all patients. Anaesthesia was induced with suxamethonium and propofol, and maintained using a combination of nitrous oxide, oxygen and isoflurane. SAMPLE 
PREPARATION
The free and protein bound leucine in the tissue biopsies were separated by pulverising the frozen tissue, homogenising in 0.2 M HC104 at 4°C and centrifuging at 2800 g for 20 minutes. The supernatant containing the free leucine was neutralised with 1 M KOH at 4°C and centrifuged to remove excess KC104. This supernatant was used for measurement of isotopic enrichment of free leucine. The protein precipitate was washed with HC104, dissolved in 0.3 M NaOH at 37°C for one hour and then reprecipitated with 2 M HC104. The protein pellet was washed again with 0-2 M HC104, before hydrolysing in 6 M hydrochloric acid for 24 hours at 110°C. After hydrolysis, the hydrochloric acid was removed by evaporation in vacuo, and the remaining sample used for the measurement of isotopic enrichment of leucine in protein.
Preparation of plasma for determination of isotopic enrichment of free leucine was performed as described previously. '5 MEASUREMENT OF "3C ENRICHMENTS Plasma and tissuefree leucine
The enrichment of plasma free leucine was measured using a VG 12-250 quadrupole gas chromatograph mass spectrometer (VG, Masslab, Manchester, UK), after conversion to the tertiary butyldimethylsilyl derivative. The ion peaks at m/z 302 and 303 were monitored under electron impact and selective ion recording conditions.18
The enrichment of tissue free leucine was also measured using GCMS after conversion of leucine to the N-butyl heptafluorobutyryl isobutyl derivative.19 Chemical ionization, with methane as the reactant gas, and selective ion recording ofthe ion peaks at m/z 363 and 364 was used.
Protein bound leucine Leucine was separated from other amino acids in the protein hydrolysate by preparative ion exchange chromatography. Leucine-CO2 was liberated by reaction with ninhydrin at pH 2.2,20 and its enrichment measured along the lines described by Halliday and Reid2' using a gas isotope ratio mass spectrometer, SIRA 12 (VG Isogas, Middlewhich, Cheshire, UK).
CALCULATIONS
The fractional rate of protein synthesis in the tissue was calculated from the formula described by McNurlan et a122; ks=(p(t)-P(o) x 100/A where, ks is the fractional rate of protein synthesis (% per day), P(o) and P(t) are the enrichments of leucine in tissue protein at the beginning and end of the incorporation period (atom %) and A is the area under the curve for precursor enrichment (atom % excessxtime in days), assuming a linear increase from 0 to the measured value at 10 minutes. P(o) was taken to equal the enrichment of a zero time sample of plasma proteins.23 STATISTICAL 
ANALYSIS
The significance of differences between means was assessed using the Mann Whitney U test.
Results
The clinical details of the patients studied are shown in Tables I and II. The mean age of patients in the colorectal cancer and benign colorectal tumour groups was higher than that of the inflammatory bowel and normal rectal mucosa groups, as would be expected from the age distributions of surgery for these different pathologies. The nutritional status of all groups, however, as assessed by body mass index (body weight/height2) was comparable.
PLASMA AND BIOPSY FREE LEUCINE "3C
ENRICHMENTS
The time course of the plasma free leucine enrichment after the 'flooding dose' (Fig 1) , showed peak enrichment immediately after the leucine infusion had finished followed by a linear fall in all subjects. One of the criteria for 'flooding' is that different amino acid pools should reach similar enrichments. In order to determine if this had occurred, the biopsy free leucine enrichments were measured and compared with the plasma free leucine enrichment at the time of taking the biopsy. This was expressed as a ratio of biopsy/ plasma free leucine enrichment. These ratios were 0.92 (0.03), 0.88 (0.02), 090 (0.02), and 0.85 (0.02) (means (SEM)) for normal mucosa, benign tumour, malignant tumour and inflamed mucosa, respectively. In the liver biopsies the ratios were 0.84 (0.02), 0-86 (0.04), and 0.81 (0.05) for benign gastrointestinal disease, colorectal cancer and inflammatory bowel disease groups of patients respectively.
TISSUE PROTEIN SYNTHESIS RATES
The fractional rate of protein synthesis in normal colonic mucosa was 9.4 (1.2)% per day (mean (SEM)), but was significantly raised in all the pathological conditions studied (p<0-001). The values were, 36.7 (2.5)% per day in benign colorectal tumour tissue, 21.7 (1-9)% per day in malignant colorectal tissue, and 24.7 (2.5)% per day in rectal mucosa from patients with inflammatory bowel disease (Fig 2) .
Liver fractional protein synthetic rates in the three groups of patients are shown in Figure 3 . The values were 20-7 (1-9)% per day in patients in the benign group, and 23-1 (1.6)% per day in patients with colorectal cancer. In the patients with inflammatory bowel disease, however, liver protein synthesis was significantly raised to 35.4 (2-3)%/day (p<0 01). group.bmj.com on July 1, 2017 -Published by http://gut.bmj.com/ Downloaded from
